Drug profile · INN
saxagliptin + dapagliflozin
QTERN 5/10
saxagliptin + dapagliflozin (QTERN 5/10) is an FDA-listed pharmaceutical active ingredient. Associated with AstraZeneca.
TGA: approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — saxagliptin + dapagliflozin
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.81
Quick answer
saxagliptin + dapagliflozin (QTERN 5/10) is an FDA-listed pharmaceutical active ingredient. Associated with AstraZeneca.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
Frequently asked questions
What is saxagliptin + dapagliflozin?
saxagliptin + dapagliflozin (QTERN 5/10) is an FDA-listed pharmaceutical active ingredient. Associated with AstraZeneca.
What is the brand name for saxagliptin + dapagliflozin?
QTERN 5/10 is a marketed brand name for saxagliptin + dapagliflozin. Check FDA Drugs@FDA for the current US label holder and prescribing information.